The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/11433128

Download in:

View as

General Info

PMID
11433128